A novel regimen for poor-prognosis or relapsed germ cell tumors

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷 / 11期
关键词：
D O I：
10.1038/ncponc0947x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：583 / 583
相关论文
共 50 条
  • [41] IMPROVING THE POOR-PROGNOSIS OF ORAL SQUAMOUS-CELL CARCINOMA
    HUTCHISON, IL
    BRITISH MEDICAL JOURNAL, 1994, 308 (6930): : 669 - 670
  • [42] A phase III trial of personalized chemotherapy based on serum tumor marker decline in poor-prognosis germ-cell tumors: Results of GETUG 13.
    Fizazi, Karim
    Pagliaro, Lance C.
    Flechon, Aude
    Mardiak, Jozef
    Geoffrois, Lionnel
    Kerbrat, Pierre
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Malhaire, Jean-pierre
    Linassier, Claude
    Habiban, Muriel
    Journeau, Florence
    Logothetis, Christopher
    Culine, Stephane
    Laplanche, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Determination of efficacy of TIP combination (paclitaxel, ifosfamide, cisplatin) as first salvage therapy for patients with relapsed germ cell tumors in a poor prognosis group
    Mardiak, J.
    Rejlekova, K.
    Mego, M.
    Rajec, J.
    Sycova-Mila, Z.
    Obertova, J.
    Salek, T.
    Reckova, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Assessment of bleomycin pulmonary toxicity in men with poor-prognosis non-seminomatous germ-cell tumors treated in the GETUG 13 phase III trial
    Naoun, N.
    Le Teuff, G.
    Pagliaro, L.
    Flechon, A.
    Mardiak, J.
    Geoffrois, L.
    Kerbrat, P.
    Chevreau, C. M.
    Delva, R.
    Rolland, F.
    Theodore, C.
    Roubaud, G.
    Gravis, G.
    Eymard, J-C.
    Malhaire, J. P.
    Linassier, C.
    Reckova, M.
    Nenan, S.
    Culine, S.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S719 - S719
  • [45] MYC regulation of a "poor-prognosis" metastatic cancer cell state
    Wolfer, Anita
    Wittner, Ben S.
    Irimia, Daniel
    Flavin, Richard J.
    Lupien, Mathieu
    Gunawardane, Ruwanthi N.
    Meyer, Clifford A.
    Lightcap, Eric S.
    Tamayo, Pablo
    Mesirov, Jill P.
    Liu, X. Shirley
    Shioda, Toshi
    Toner, Mehmet
    Loda, Massimo
    Brown, Myles
    Brugge, Joan S.
    Ramaswamy, Sridhar
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (08) : 3698 - 3703
  • [46] Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis
    van Laar, Jacob M.
    Naraghi, Kamran
    Tyndall, Alan
    RHEUMATOLOGY, 2015, 54 (12) : 2126 - 2133
  • [47] Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial
    Fizazi, Karim
    Le Teuff, Gwenael
    Flechon, Aude
    Pagliaro, Lance
    Mardiak, Josef
    Geoffrois, Lionnel
    Laguerre, Brigitte
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Cancel, Mathilde
    Juzyna, Beata
    Reckova, Maria
    Naoun, Natacha
    Logothetis, Christopher
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [48] Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
    Loriot, Y.
    Pagliaro, L.
    Flechon, A.
    Mardiak, J.
    Geoffrois, L.
    Kerbrat, P.
    Chevreau, C.
    Delva, R.
    Rolland, F.
    Theodore, C.
    Roubaud, G.
    Gravis, G.
    Eymard, J. C.
    Malhaire, J. P.
    Linassier, C.
    Habibian, M.
    Martin, A. L.
    Journeau, F.
    Reckova, M.
    Logothetis, C.
    Laplanche, A.
    Le Teuff, G.
    Culine, S.
    Fizazi, K.
    EUROPEAN JOURNAL OF CANCER, 2017, 87 : 140 - 146
  • [49] High-dose thiotepa and etoposide in children with poor-prognosis brain tumors
    Fagioli, F
    Biasin, E
    Mastrodicasa, L
    Sandri, A
    Ferrero, L
    Berger, M
    Vassallo, E
    Madon, E
    CANCER, 2004, 100 (10) : 2215 - 2221
  • [50] GAMEC - A novel protocol for IGCCCG poor prognosis and relapsing germ cell tumours
    Shamash, J
    Oliver, RTD
    Steele, JPC
    Ansell, W
    Millard, L
    GERM CELL TUMOURS V, 2002, : 240 - 241
12345